Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. FDA Record
Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Evonik Rexim (Nanning) Pharmaceutical Co. Ltd." is on file.
- Latest inspection
- Apr 11, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 3 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 11, 2025 | Nanning, China | Drugs | No Action Indicated (NAI) | 3004268442 |
| Sep 28, 2018 | Nanning, China | Drugs | Voluntary Action Indicated (VAI) | 3004268442 |
| Nov 13, 2015 | Nanning, China | Drugs | Voluntary Action Indicated (VAI) | 3004268442 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3004268442 | Nanning, China | 3 | Apr 11, 2025 |
Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. and the FDA: common questions
Has Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. received an FDA warning letter?
No FDA warning letter addressed to the name "Evonik Rexim (Nanning) Pharmaceutical Co. Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Evonik Rexim (Nanning) Pharmaceutical Co. Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.?
The most recent FDA inspection on file ended Apr 11, 2025 at Nanning, China and was classified NAI. FDA has 3 inspections of Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. on file.
Need more than this page shows? Ask about Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.